Woltering EA - Search Results

1

Development of 125I-methylene blue for sentinel lymph node biopsy.

Stafford SJ, Wright JL, Schwimer J, Anthony CT, Cundiff JD, Thomson JL, Wang YZ, Espenan G, Maloney T, Camp A, Woltering EA. Stafford SJ, et al. Among authors: woltering ea. J Surg Oncol. 2006 Sep 15;94(4):293-7. doi: 10.1002/jso.20444. J Surg Oncol. 2006. PMID: 16917874

2

A phase I/II trial of 125I methylene blue for one-stage sentinel lymph node biopsy.

Cundiff JD, Wang YZ, Espenan G, Maloney T, Camp A, Lazarus L, Stolier A, Brooks R, Torrance B, Stafford S, O'Leary JP, Woltering EA. Cundiff JD, et al. Among authors: woltering ea. Ann Surg. 2007 Feb;245(2):290-6. doi: 10.1097/01.sla.0000242712.74502.72. Ann Surg. 2007. PMID: 17245184 Free PMC article. Clinical Trial.

3

An extended phase II trial of iodine-125 methylene blue for sentinel lymph node identification in women with breast cancer.

Harkrider WW, Diebold AE, Maloney T, Espenan G, Wang YZ, Stafford SJ, Camp A, Frey D, Chappuis C, Woltering EA. Harkrider WW, et al. Among authors: woltering ea. J Am Coll Surg. 2013 Apr;216(4):599-605; discussion 605-6. doi: 10.1016/j.jamcollsurg.2012.12.044. J Am Coll Surg. 2013. PMID: 23521938 Clinical Trial.

4

Intraoperative gamma detection of 125I-lanreotide in women with primary breast cancer.

Cuntz MC, Levine EA, O'Dorisio TM, Watson JC, Wray DA, Espenan GD, McKnight C, Meier JR, Weber LJ, Mera R, O'Dorisio MS, Woltering EA. Cuntz MC, et al. Among authors: woltering ea. Ann Surg Oncol. 1999 Jun;6(4):367-72. doi: 10.1007/s10434-999-0367-y. Ann Surg Oncol. 1999. PMID: 10379857 Clinical Trial.

5

A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.

Lyons JM 3rd, Anthony CT, Thomson JL, Woltering EA. Lyons JM 3rd, et al. Among authors: woltering ea. Ann Surg Oncol. 2008 Dec;15(12):3407-14. doi: 10.1245/s10434-008-0145-2. Epub 2008 Sep 16. Ann Surg Oncol. 2008. PMID: 18795370

6

In vitro chemoresistance testing in well-differentiated carcinoid tumors.

Lyons JM 3rd, Abergel J, Thomson JL, Anthony CT, Wang YZ, Anthony LB, Boudreaux JP, Strauchen J, Idrees M, Warner RR, Woltering EA. Lyons JM 3rd, et al. Among authors: woltering ea. Ann Surg Oncol. 2009 Mar;16(3):649-55. doi: 10.1245/s10434-008-0261-z. Epub 2009 Jan 8. Ann Surg Oncol. 2009. PMID: 19130141

7

The role of VEGF pathways in human physiologic and pathologic angiogenesis.

Lyons JM 3rd, Schwimer JE, Anthony CT, Thomson JL, Cundiff JD, Casey DT, Maccini C, Kucera P, Wang YZ, Boudreaux JP, Woltering EA. Lyons JM 3rd, et al. Among authors: woltering ea. J Surg Res. 2010 Mar;159(1):517-27. doi: 10.1016/j.jss.2008.12.014. Epub 2009 Jan 10. J Surg Res. 2010. PMID: 19577260

8

Metronomic dosing enhances the anti-angiogenic effect of epothilone B.

Stalder MW, Anthony CT, Woltering EA. Stalder MW, et al. Among authors: woltering ea. J Surg Res. 2011 Aug;169(2):247-56. doi: 10.1016/j.jss.2009.12.001. Epub 2009 Dec 30. J Surg Res. 2011. PMID: 20338584 Free PMC article.

9

Do primary neuroendocrine tumors and metastasis have the same characteristics?

Lindholm EB, Lyons J 3rd, Anthony CT, Boudreaux JP, Wang YZ, Woltering EA. Lindholm EB, et al. Among authors: woltering ea. J Surg Res. 2012 May 15;174(2):200-6. doi: 10.1016/j.jss.2011.11.1038. Epub 2011 Dec 21. J Surg Res. 2012. PMID: 22341351

10

Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity.

Meyers MO, Anthony CT, Coy DH, Murphy WA, Drouant GJ, Fuselier J, Espenan GD, Maloney TJ, Woltering EA. Meyers MO, et al. Among authors: woltering ea. J Surg Res. 1998 May;76(2):154-8. doi: 10.1006/jsre.1998.5313. J Surg Res. 1998. PMID: 9698516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters